In diabetic cardiomyopathy, BMAL1 overexpression enhanced BMAL1/BCL2 binding, which suppressed IP3R activity, reduced mitochondrial Ca2+ overload, and attenuated subsequent apoptosis [47]. This evidence concerns the gene BCL2 and diabetic cardiomyopathy.